Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

California could tap nonprofit Civica Rx to produce insulin

By Brian Buntz | November 15, 2022

Insulin

[Image courtesy of ayo888 via iStock Photo]

The state of California is reportedly planning to work with the nonprofit generic drug company Civica Rx to produce the hormone, according to NBC. California could confirm the partnership in mid-December, but the partnership has not yet been verified.

This summer, California Governor Gavin Newsom hinted that the state planned to manufacture insulin to help people with diabetes save money.

California would likely be the first state to produce insulin for residents.

A state-run website concluded that California has the highest number of new diabetes cases in the U.S.

In March, Lehi, Utah–based Civica Rx announced that it intended to manufacture low-cost insulin. The organization said then that it would set the recommended consumer price at a maximum of $30 per vial or $55 for a box of five pen cartridges.

In March, the Juvenile Diabetes Research Foundation (JDRF) announced that it would partner with Civica Rx to develop insulin biosimilars.

The analyst firm GlobalData anticipates that greater availability of biosimilar insulins could ultimately lead to lower insulin prices across the marketplace.

Some insulins cost multiple hundreds of dollars. A vial of Humalog insulin, for instance, costs $393.00 per vial, according to GoodRx Health.

Roughly a quarter of patients ration their insulin or skip taking insulin doses, which can damage nerves, blood vessels and vital organs while potentially exacerbating diabetes-related disability. In extreme cases, poor insulin affordability can lead to renal disease, amputations or death.

Governor Gavin Newsom campaigned on lowering prescription drug prices and, in early 2019, touted a series of initiatives intended to tackle spiraling healthcare costs. Among those initiatives was a plan to create a single-purchaser system for prescription drugs.

President Joe Biden is also aiming to reduce the cost of insulin. The Inflation Reduction Act, which the President signed into law in August, would cap the out-of-pocket price of insulin at $35 for Medicare recipients beginning in 2023.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE